CVS vs VXRT · P/E 16, rev $402.07B vs rev $28.7M
CVS Health Corp (CVS) versus Vaxart Inc (VXRT) — a side-by-side from cached financials, not a winner call.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
Vaxart Inc (VXRT) is a biotechnology company listed on US.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Latest reported VXRT revenue for 2024-12-31 was $28.7M. Net income was -$66.9M. Revenue was up 288.9% from 2023-12-31 to 2024-12-31. VXRT currently screens at market cap $73.0M.
CVS currently screens at market cap $86.20B and trailing P/E 16.3. VXRT currently screens at market cap $73.0M.
Not investment advice. Open the CVS and VXRT stock pages for the full models.
Not investment advice.